Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gisella Vischini

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Current Drug Targets|January 1, 2010
The use of major analgesics in patients with renal dysfunctionPasquale Niscola, Laura Scaramucci, Gisella Vischini, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|November 3, 2025
Renal Complications in Solid Tumor Patients Referred to an Onconephrology Clinic: A Three-Year Italian ExperienceAnita Campus, Gisella Vischini, Daniele Vetrano, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 4, 2017
Heparanase regulates the M1 polarization of renal macrophages and their crosstalk with renal epithelial tubular cells after ischemia/reperfusion injuryValentina Masola, Gianluigi Zaza, Gloria Bellin, et al.
Nephron|April 6, 2025
The Fabry Nephropathy in Patients with N215S VariantRenzo Mignani, Gian Marco Berti, Gisella Vischini, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|June 1, 2011
[Opioid analgesics in patients with chronic renal failure: principles for use and current guidelines]Pasquale Niscola, Marco Giovannini, Gisella Vischini, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|July 31, 2012
[Membranous glomerulonephritis secondary to allogeneic stem cell transplant: review of the literature]Gisella Vischini, Pasquale Niscola, Michele Ferrannini, et al.
Indian Journal of Palliative Care|October 7, 2011
Management of Peritoneal Dialysis within a Home Care Program for Hematological Malignancies: Concerns and Perspectives Illustrated by a Case ReportGisella Vischini, Pasquale Niscola, Andrea Tendas, et al.
Journal of Nephrology|March 3, 2018
Defective activation of the MAPK/ERK pathway, leading to PARP1 and DNMT1 dysregulation, is a common defect in IgA nephropathy and Henoch-Schönlein purpuraAnnamaria Milillo, Clelia Molinario, Stefano Costanzi, et al.
Journal of Nephrology|July 22, 2023
Caveolin-1 in situ expression in glomerular and peritubular capillaries as a marker of ultrastructural progression and severity of renal thrombotic microangiopathyFrancesco Vasuri, Anthony P Lisi, Carmen Ciavarella, et al.
International Journal of Molecular Sciences|January 10, 2026
Coexistence of Alport Syndrome and Fabry Disease in a Female with R112H Variant: Early Progression of Fabry NephropathyAmedeo Grimaldi, Alessandra Auletta, Francesca Ciurli, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Current Drug Targets|January 1, 2010
The use of major analgesics in patients with renal dysfunctionPasquale Niscola, Laura Scaramucci, Gisella Vischini, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|November 3, 2025
Renal Complications in Solid Tumor Patients Referred to an Onconephrology Clinic: A Three-Year Italian ExperienceAnita Campus, Gisella Vischini, Daniele Vetrano, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 4, 2017
Heparanase regulates the M1 polarization of renal macrophages and their crosstalk with renal epithelial tubular cells after ischemia/reperfusion injuryValentina Masola, Gianluigi Zaza, Gloria Bellin, et al.
Nephron|April 6, 2025
The Fabry Nephropathy in Patients with N215S VariantRenzo Mignani, Gian Marco Berti, Gisella Vischini, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|June 1, 2011
[Opioid analgesics in patients with chronic renal failure: principles for use and current guidelines]Pasquale Niscola, Marco Giovannini, Gisella Vischini, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|July 31, 2012
[Membranous glomerulonephritis secondary to allogeneic stem cell transplant: review of the literature]Gisella Vischini, Pasquale Niscola, Michele Ferrannini, et al.
Indian Journal of Palliative Care|October 7, 2011
Management of Peritoneal Dialysis within a Home Care Program for Hematological Malignancies: Concerns and Perspectives Illustrated by a Case ReportGisella Vischini, Pasquale Niscola, Andrea Tendas, et al.
Journal of Nephrology|March 3, 2018
Defective activation of the MAPK/ERK pathway, leading to PARP1 and DNMT1 dysregulation, is a common defect in IgA nephropathy and Henoch-Schönlein purpuraAnnamaria Milillo, Clelia Molinario, Stefano Costanzi, et al.
Journal of Nephrology|July 22, 2023
Caveolin-1 in situ expression in glomerular and peritubular capillaries as a marker of ultrastructural progression and severity of renal thrombotic microangiopathyFrancesco Vasuri, Anthony P Lisi, Carmen Ciavarella, et al.
International Journal of Molecular Sciences|January 10, 2026
Coexistence of Alport Syndrome and Fabry Disease in a Female with R112H Variant: Early Progression of Fabry NephropathyAmedeo Grimaldi, Alessandra Auletta, Francesca Ciurli, et al.
Pageof 5